are compound semaglutide going away Did the FDA Ban Compounded and Tirzepatide? Compounded GLP-1 - Semaglutide &

Prescription GLP-1 agonists like semaglutide have shown remarkable results in clinical trials, with users experiencing significant reductions in body weight alongside improvements in cardiovascular risk factors.Beyond weight loss, GLP-1 support contributes to broader health benefits, including better lipid profiles, reduced inflammation, and potential protection against heart disease and kidney complications

This reduces the risk of hypoglycaemia compared to some other diabetes treatments

Selling them labeled "for research use only" is currently permitted

GLP-1, an originally identified natural prototype, is synthesized and secreted by intestinal enteroendocrine L-cells and certain neurons within the nucleus of the solitary tract in the brainstem [2]